Cannabis Banking's Last Mile: Why Rescheduling Alone Won't Open Bank Doors

When the DOJ moved medical marijuana to Schedule III on April 23, cannabis operators celebrated — and understandably so. The 280E tax relief alone will save the industry hundreds of millions of dollars. But amid the champagne toasts and stock rallies, a stubborn reality persists: most cannabis businesses still can't open a basic checking account at their local bank. And rescheduling, by itself, won't change that.

The cannabis banking problem is the industry's most paradoxical challenge. Here is a $38.5 billion legal industry — larger than the craft beer market, bigger than the organic food sector — that operates in a financial twilight zone where cash is king not by choice but by necessity. Understanding why requires looking beyond the headlines to the structural barriers that rescheduling alone cannot dismantle.

The Problem Isn't What You Think

The common narrative is straightforward: marijuana is federally illegal, so banks won't touch it. Schedule III fixes the illegality problem, so banking follows. This narrative is wrong — or at least, dangerously incomplete.

The real barrier isn't the Controlled Substances Act per se. It's the Bank Secrecy Act (BSA), anti-money laundering (AML) regulations, and the deeply risk-averse compliance culture that governs American financial institutions.

Under federal banking regulations, any institution that provides services to a cannabis business must file Suspicious Activity Reports (SARs) with the Financial Crimes Enforcement Network (FinCEN) for every transaction. Not just suspicious transactions — every transaction. A dispensary depositing its Tuesday receipts triggers the same reporting requirement as a transaction that actually looks fraudulent.

This isn't a technicality. Each SAR requires documentation, review, and submission. For a bank serving multiple cannabis clients, the compliance burden can consume entire departments. And the consequences of getting it wrong are existential: federal regulators can fine banks, revoke charters, or pursue criminal charges against officers who fail to meet BSA/AML obligations.

Moving marijuana from Schedule I to Schedule III doesn't eliminate this compliance architecture. Cannabis remains a controlled substance under Schedule III, and the FinCEN guidance requiring SARs for cannabis businesses has not been rescinded or modified as part of the rescheduling action.

The Numbers Tell the Story

As of early 2026, approximately 812 banks and credit unions in the United States reported serving cannabis businesses — out of roughly 9,000 total institutions. That's less than 10% participation, and the number has actually declined from a peak of 847 in late 2024 as some institutions exited the market after concluding that the compliance costs outweighed the revenue.

The institutions that do serve cannabis tend to be small community banks and credit unions that have built specialized compliance teams and charge premium fees for their services. Cannabis businesses routinely pay monthly account fees of $2,000 to $5,000 or more, compared to the $10 to $25 monthly fee that a comparable non-cannabis business would pay. Some cannabis banking specialists charge percentage-based fees on deposits, effectively creating a tax on cash flow that compounds the already-heavy regulatory tax burden.

These fees aren't gouging — they reflect genuine costs. Building and maintaining a cannabis-compliant banking operation requires specialized software, dedicated compliance staff, ongoing training, and the ever-present risk that a regulatory examiner will disagree with the institution's approach and impose penalties.

The SAFER Banking Act: The Real Solution?

The most promising path to cannabis banking access isn't rescheduling — it's legislation. The SAFER (Secure and Fair Enforcement Regulation) Banking Act, reintroduced in Congress this week with 14 bipartisan Senate cosponsors, would provide explicit federal protections for financial institutions that serve state-legal cannabis businesses.

The bill would prohibit federal banking regulators from penalizing, threatening, or discouraging institutions from providing services to cannabis businesses operating in compliance with state law. It would create a safe harbor — a legal shield — that eliminates the existential risk that currently keeps most banks on the sidelines.

The SAFER Act has been introduced, in some form, eight times since 2013. It has passed the House multiple times but has never cleared the Senate. Sponsors argue that rescheduling momentum gives it the best chance yet, as the political alignment between a rescheduling-friendly administration and a Congress increasingly comfortable with cannabis reform creates a narrow window of opportunity.

But "best chance yet" is relative. The bill still faces opposition from banking industry conservatives who argue that any federal cannabis banking framework must wait for comprehensive federal legalization, and from some anti-cannabis groups who view banking access as a step toward normalization they oppose.

What Rescheduling Does Help With

This isn't to say that Schedule III reclassification has no effect on banking. It does — but the effects are indirect and incremental rather than transformative.

First, rescheduling reduces the perceived risk for financial institutions. A Schedule III substance carries less stigma than a Schedule I substance, and bank compliance officers can more easily justify serving an industry whose product is in the same federal category as ketamine or Tylenol with codeine. Perception matters in regulatory compliance, even when the formal rules haven't changed.

Second, the elimination of 280E for medical cannabis businesses will improve the financial health of operators, making them more attractive banking clients. Banks evaluate creditworthiness and risk based on financial statements. When those statements stop showing 70% effective tax rates and start reflecting standard business economics, the numbers tell a very different story.

Third, the DOJ's rescheduling action signals political direction. Federal regulators — including FinCEN, the Office of the Comptroller of the Currency, and the FDIC — take cues from the broader political environment. An administration that has actively moved to reschedule cannabis is unlikely to simultaneously crack down on banks that serve the industry. This implicit permission, while legally fragile, provides practical comfort to institutions on the fence.

The Cash Problem and Public Safety

The banking gap isn't just an inconvenience — it's a public safety issue. Cannabis businesses that can't access banking services operate as cash-only enterprises. Cash businesses attract robberies, complicate tax compliance, hinder regulatory oversight, and create fertile ground for the very money laundering that BSA regulations were designed to prevent.

The irony is profound: the regulations meant to prevent financial crime are forcing an entire industry into a cash-based model that makes financial crime easier. Dispensary workers face armed robberies. Business owners transport cash in unmarked vehicles. Tax payments require physical delivery of cash to IRS offices.

In states with large legal markets, the scale of cash handling has become a logistical and security challenge that absorbs resources, increases insurance costs, and puts employees at risk.

What Happens Next

The most likely path to resolution involves both rescheduling and legislation working in tandem. Full rescheduling through the June DEA hearings would further reduce the risk calculus for financial institutions, while the SAFER Banking Act would provide the legal certainty that risk reduction alone cannot achieve.

In the meantime, innovation is filling some of the gaps. Fintech companies have developed cannabis-specific payment processing solutions, cashless ATM systems, and digital payment platforms that route around traditional banking barriers. These solutions are imperfect — they're often more expensive than traditional banking and may face their own regulatory challenges — but they demonstrate the market's determination to solve a problem that policy has been slow to address.

For cannabis businesses navigating the current landscape, the advice from industry financial consultants remains frustratingly practical: build relationships with cannabis-friendly institutions now, maintain impeccable compliance records, and prepare for the possibility that meaningful banking reform is still measured in years rather than months.

The road to cannabis banking runs through both the DEA hearing room and the halls of Congress. Until both deliver, the industry's cash problem will persist — Schedule III or not.

Related reading: The full DOJ Schedule III order explained · How cannabis operators save millions when 280E ends · The June 29 DEA hearings: what a full rescheduling would mean

Explore cannabis news, find dispensaries, and join the community at Budpedia.